The ratings of 16 Health Care Equipment & Supplies stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
STERIS Plc’s (STE) rating weakens this week, dropping to a D versus last week’s C. STERIS Plc provides products and services related to infection prevention and surgical procedures. For more information, get Portfolio Grader’s complete analysis of STE stock.
DENTSPLY SIRONA, Inc. (XRAY) is having a tough week. The company’s rating falls from a C to a D. DENTSPLY SIRONA, Inc. designs and manufactures a range of dental products. For more information, get Portfolio Grader’s complete analysis of XRAY stock.
Neogen Corporation (NEOG) slips from a C to a D this week. Neogen Corporation develops and markets products and services dedicated to food and animal safety. For more information, get Portfolio Grader’s complete analysis of NEOG stock.
Natus Medical Incorporated (BABY) experiences a ratings drop this week, going from last week’s C to a D. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. For more information, get Portfolio Grader’s complete analysis of BABY stock.
Hologic, Inc. (HOLX) earns a D this week, moving down from last week’s grade of C. Hologic, Inc. develops, manufactures, and markets x-ray systems. For more information, get Portfolio Grader’s complete analysis of HOLX stock.
Slipping from a C to a D rating, Haemonetics Corporation (HAE) takes a hit this week. Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The company also gets F’s in operating margin growth. For more information, get Portfolio Grader’s complete analysis of HAE stock.
Meridian Bioscience, Inc. (VIVO) declines this week from a C to a D. Meridian Bioscience, Inc. manufactures diagnostic test kits, bulk antigens, antibodies and bioresearch reagents used by researchers and other diagnostic manufacturers. For more information, get Portfolio Grader’s complete analysis of VIVO stock.
This week, Novadaq Technologies Inc. (NVDQ) drops from a C to a D rating. Novadaq Technologies Inc. develops and commercializes medical devices based on its proprietary imaging platform for the diagnosis and treatment of human vascular and opthalmic diseases and conditions. The company also gets F’s in earnings surprise and return on equity. For more information, get Portfolio Grader’s complete analysis of NVDQ stock.
Tandem Diabetes Care, Inc. (TNDM) gets weaker ratings this week as last week’s C drops to a D. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of TNDM stock.
This week, CytoSorbents Corporation’s (CTSO) rating worsens to a D from the company’s C rating a week ago. The company also gets F’s in earnings growth, earnings revisions, earnings surprise, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of CTSO stock.
This is a rough week for Viveve Medical Inc (VIVE). The company’s rating falls to D from the previous week’s C. The company also gets F’s in earnings revisions, earnings surprise, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of VIVE stock.
Accuray Incorporated (ARAY) experiences a ratings drop this week, going from last week’s C to a F. Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The company also gets F’s in earnings revisions, earnings surprise, and return on equity. For more information, get Portfolio Grader’s complete analysis of ARAY stock.
Ekso Bionics Holdings, Inc.’s (EKSO) rating weakens this week, dropping to a D versus last week’s C. The company also gets F’s in sales growth, earnings revisions, earnings surprise, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of EKSO stock.
This week, DarioHealth Corp.’s (DRIO) rating worsens to a D from the company’s C rating a week ago. The company also gets F’s in earnings revisions, earnings surprise, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of DRIO stock.
ReWalk Robotics Ltd. (RWLK) slips from a C to a D this week. The company also gets F’s in earnings revisions, earnings surprise, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of RWLK stock.
ViewRay, Inc. (VRAY) earns a D this week, moving down from last week’s grade of C. The company also gets F’s in free cash flow. For more information, get Portfolio Grader’s complete analysis of VRAY stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
